Anti-aging ingredient ready for market

Dec 16, 2006

A new anti-aging ingredient developed by university researchers in Australia may be available in skin products as soon as next year.

Known as GGC, the ingredient is a forerunner for the anti-oxidant glutathione and has a number of possible health benefits, the University of New South Wales researchers said. Glutathione is a defense for detoxifying harmful compounds implicated in cancer, diabetes, aging and other diseases and degenerative conditions in the body.

University researchers said after nine years they developed a new, cost-effective way to manufacture GGC, which has been licensed to Biospecialties Australia.

Researchers said they expected the ingredient would be used in foods, health and beauty products, dietary supplements and anti-aging creams.

Natural dietary sources of GGC are available, including milk whey protein and garlic in diluted concentrations, researchers said. The new GGC product could allow for more effective doses.

Copyright 2006 by United Press International

Explore further: Physicians warned about counterfeit medical devices

add to favorites email to friend print save as pdf

Related Stories

New hope for wrinkles

Dec 15, 2006

A new anti-aging ingredient developed by Australian researchers is expected to be available in skin products next year. The new additive - gamma glutamyl cysteine (GGC) - is a precursor for an effective antioxidant known ...

Recommended for you

EU regulator: Morning-after pill OK for all women

12 hours ago

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

16 hours ago

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

Zydelig approved for three types of blood cancer

17 hours ago

(HealthDay)—Zydelig (idelalisib) has been approved by the U.S. Food and Drug Administration to treat relapsed forms of blood cancer, including chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL) ...

Journal raises concern about blood-thinning drug

Jul 23, 2014

A medical journal raised concerns Wednesday about a blood-thinning drug widely used by people at risk of stroke, accusing its manufacturer of concealing safety data and regulators of laxness.

User comments : 0